A1RG34:BVMF
Argenx Se Bdr
R$ 222.17
0.00%
(0.00) 1D
11-р сарын 12, 15:02:53 (GMT-3) · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Mkt. cap
55.08 тэрбум
Avg. vol.
55.00
Volume
0.00
52-wk high
R$ 222.17
52-wk low
R$ 143.22
Shares outstanding
62.89 сая
No. of employees
2 мян
Mkt. cap
55.08 тэрбум
Avg. vol.
55.00
Volume
0.00
52-wk high
R$ 222.17
52-wk low
R$ 143.22
Shares outstanding
62.89 сая
No. of employees
2 мян
News stories
From web sources and news partners
ProFinance
·
8 цагийн өмнө
Опытный стратег видит в расколе фондового рынка предпосылки для падения S&P 500 на 15%
Интерфакс
·
18 цагийн өмнө
Индексы S&P 500 и Nasdaq в пятницу снизились
Forbes.ru
·
3 өдрийн өмнө
Goldman Sachs спрогнозировал рост S&P 500 до 8700 пунктов на горизонте года
Yahoo Finance
·
9 минутын өмнө
What's dragging down the S&P 500? Apple in focus
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr
CEO-
Employees1.86 мян
Founded2008 оны 4-р сарын 25
Headquarters-
SectorHealth Care
Industry-
Websiteargenx.com